Literature DB >> 1197914

The influence of delta9-tetrahydrocannabinol, cannabinol and cannabidiol on tissue oxygen consumption.

P Chiu, R Karler, C Craven, D M Olsen, S A Turkanis.   

Abstract

The mechanism of the hypothermia produced in mice by the naturally occurring cannabinoids, delta9-tetrahydrocannabinol, cannabinol, and cannabidiol, was investigated by evaluating the direct effect of these drugs on the oxygen consumption of tissue homogenates and isolated mitochondria. The tissues studied were brain, liver, skeletal muscle, and heart; the mitochondrial preparations were limited to brain and skeletal muscle. The in-vitro studies included a description of the influence of various cannabinoid vehicles containing Tween 80, ethanol, Pluronic F68, and albumin on the oxygen consumption of tissue preparations. Of these vehicles, only albumin was without effect on all tissues. The other vehicles produced diverse responses, including some that were qualitatively different; the data illustrate that the influence of each vehicle on oxygen consumption must be defined for each tissue employed. In spite of the different vehicle effects, delta9-tetrahydrocannabinol generally reduced oxygen consumption of all tissue preparations; however, the vehicles were capable of modifying the dose-effect relationship. The results of all three drugs prepared in Pluronic F68 on brain and skeletal muscle indicated that the cannabinoids generally cause a dose-related depression of oxygen consumption. The findings demonstrate that the cannabinoids can directly decrease oxidative metabolism of tissue and isolated mitochondria and that a marked response occurs in the concentration range of 1 X 10(-5) to 1 X 10(-4) M. Because these concentrations can exist in tissues following the in-vivo administration of delta9-tetrahydrocannabinol, the results suggest that the depressant effect of the cannabinoids on metabolic rate may contribute to the mechanism of the hypothermia produced by the drugs.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1197914

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  14 in total

1.  Physiological intestinal oxygen modulates the Caco-2 cell model and increases sensitivity to the phytocannabinoid cannabidiol.

Authors:  Tara Macpherson; Jane A Armstrong; David N Criddle; Karen L Wright
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-01-24       Impact factor: 2.416

Review 2.  Metabolic Messengers: endocannabinoids.

Authors:  Arnau Busquets-García; Juan P Bolaños; Giovanni Marsicano
Journal:  Nat Metab       Date:  2022-07-11

3.  Geospatiotemporal and causal inference study of cannabis and other drugs as risk factors for female breast cancer USA 2003-2017.

Authors:  Albert Stuart Reece; Gary Kenneth Hulse
Journal:  Environ Epigenet       Date:  2022-03-01

Review 4.  The endocannabinoid system in normal and pathological brain ageing.

Authors:  Andras Bilkei-Gorzo
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

5.  Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: the role of eNOS, p38 MAPK, and AMPK pathways.

Authors:  Laura Tedesco; Alessandra Valerio; Marta Dossena; Annalisa Cardile; Maurizio Ragni; Claudio Pagano; Uberto Pagotto; Michele O Carruba; Roberto Vettor; Enzo Nisoli
Journal:  Diabetes       Date:  2010-08-25       Impact factor: 9.461

6.  Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes.

Authors:  Laura Tedesco; Alessandra Valerio; Cristina Cervino; Annalisa Cardile; Claudio Pagano; Roberto Vettor; Renato Pasquali; Michele O Carruba; Giovanni Marsicano; Beat Lutz; Uberto Pagotto; Enzo Nisoli
Journal:  Diabetes       Date:  2008-05-13       Impact factor: 9.461

7.  Tetrahydrocannabinol induces brain mitochondrial respiratory chain dysfunction and increases oxidative stress: a potential mechanism involved in cannabis-related stroke.

Authors:  Valérie Wolff; Anna-Isabel Schlagowski; Olivier Rouyer; Anne-Laure Charles; François Singh; Cyril Auger; Valérie Schini-Kerth; Christian Marescaux; Jean-Sébastien Raul; Joffrey Zoll; Bernard Geny
Journal:  Biomed Res Int       Date:  2015-01-14       Impact factor: 3.411

Review 8.  Impacts of cannabinoid epigenetics on human development: reflections on Murphy et. al. 'cannabinoid exposure and altered DNA methylation in rat and human sperm' epigenetics 2018; 13: 1208-1221.

Authors:  Albert Stuart Reece; Gary Kenneth Hulse
Journal:  Epigenetics       Date:  2019-07-11       Impact factor: 4.528

9.  Delta-9-tetrahydrocannabinol inhibits invasion of HTR8/SVneo human extravillous trophoblast cells and negatively impacts mitochondrial function.

Authors:  O'Llenecia S Walker; Harmeet Gurm; Reeti Sharma; Navkiran Verma; Linda L May; Sandeep Raha
Journal:  Sci Rep       Date:  2021-02-17       Impact factor: 4.379

Review 10.  Therapeutic Applications of Cannabinoids in Cardiomyopathy and Heart Failure.

Authors:  J A Garza-Cervantes; M Ramos-González; O Lozano; C Jerjes-Sánchez; G García-Rivas
Journal:  Oxid Med Cell Longev       Date:  2020-10-27       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.